Here is how Laird Superfood, Inc. (LSF) and Medifast (MED) have performed compared to their sector so far this year.
Laird Superfood, Inc. (LSF) Q2 2026 Earnings Call Transcript
Laird Superfood, Inc. (LSF) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to a loss of $0.03 per share a year ago.
LSF posts a Q1 profit as sales rise 20%, with wholesale growth and acquisitions driving its expanded superfood platform.
Laird Superfood, Inc. (LSF) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.02 per share a year ago.
Laird Superfood, Inc. (LSF) Q1 2026 Earnings Call Transcript
Laird Superfood (LSF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Laird Superfood (LSF) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Laird Superfood, Inc. (LSF) Q4 2025 Earnings Call Transcript
Laird Superfood, Inc. (LSF) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.04 per share a year ago.
Laird Superfood, Inc. (LSF) M&A Call Transcript
Laird Superfood, Inc. (LSF) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.05 per share a year ago.